The North America Carcinoid Syndrome Management Market holds a significant position in the global market, driven by the increasing incidence of neuroendocrine tumors, expanding oncology research, and continuous innovation in rare disease treatments. The region benefits from advanced healthcare infrastructure, strong presence of leading pharmaceutical companies, and broad adoption of advanced...